newsfilter
← Latest News
ACCESS Newswire·

SEC Declares Form S-4 Registration Statement "Effective" for Proposed Business Combination of Murphy Canyon Acquisition Corp. with Conduit Pharmaceuticals Limited

Special meeting of Murphy Canyon stockholders to vote on the proposed business combination scheduled for September 7, 2023Conduit is a disease agnostic life science company providing an efficient model for compound